iSpecimen Inc. Unbilled Receivables, Current
iSpecimen Inc. (ISPC) had Unbilled Receivables, Current of $1.65 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:UnbilledReceivablesCurrent · last filed 2025-04-14
- 2024-09-30: Unbilled Receivables, Current $1.65M.
- 2024-06-30: Unbilled Receivables, Current $1.95M.
- 2024-03-31: Unbilled Receivables, Current $1.98M.
- 2023-12-31: Unbilled Receivables, Current $2.21M.
| Period end | Unbilled Receivables, Current |
|---|---|
| 2024-09-30 | $1.65M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.95M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.98M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $2.21M 10-K · filed 2025-04-14 |
| 2023-09-30 | $1.43M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $1.10M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $1.58M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $2.33M 10-K · filed 2024-03-13 |
| 2022-09-30 | $1.31M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.26M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.26M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.74M 10-K/A · filed 2023-03-30 |
| 2021-09-30 | $1.75M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.13M 10-Q · filed 2021-08-10 |
| 2020-12-31 | $652.76K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |